Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.045 USD | -15.57% | -2.72% | -15.27% |
03/06 | TriSalus Life Sciences, Inc. Highlights Clinical Data from Phase 1b Perio-02 Trial | CI |
30/05 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |